60
Participants
Start Date
November 30, 2015
Primary Completion Date
April 30, 2017
Study Completion Date
July 31, 2021
AmM APTITUDE Bioresorbable Drug-Eluting Coronary Scaffold
Placement of the investigational device into the diseased coronary artery to eliminate the vascular stenosis.
Clinica de Marly, Bogotá
Instituto del Corazon, Bucaramanga
EMMSA Clinica Especializada, Medellín
Angiografia De Occidente S.A., Santiago de Cali
Azienda Policlinico-Vittorio Emanuele, Universita di Catania, Catania
Azienda Ospedaliero Universitaria Careggi, Florence
Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milan
Ospedale San Raffaele, Milan
Policlinico San Donato, Milan
A. O. U. Federico II˚ Policlinico, Napoli
Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua
A. O. Ordine Mauriziano Umberto I, Torino
Lead Sponsor
Amaranth Medical Inc.
INDUSTRY